The European Breast Cancer Conference in 2016 (EBCC-10) will take place in the context of very tangible advances that have been made for patients in recent years.
These advances have been largely achieved through the successful application of a multidisciplinary approach in the treatment and care of breast cancer.
EBCC is proud to have played its role in driving these advances for breast cancer patients as a unique, dedicated multidisciplinary platform and the largest breast cancer conference outside the US.
This edition of EBCC (EBCC-10) is again firmly based on a holistic vision of breast cancer and brings together scientists, clinicians, patient representatives and health professionals of diverse profiles to tackle key issues facing patients throughout the continuum of the breast cancer journey.
The conference programme will provide the latest insights into the areas of prevention, optimal diagnosis, treatment, survivorship, the advance driven by research in all of them so that EBCC again fulfils its mission to accelerate the translation of clinical research into best practice made widely available to patients all over Europe.
EBCC-10 will replicate the highly successful “Multidisciplinary Teams in the Real World” and will have a strong focus on the work of the breast team throughout its programme.
Our aim is to strengthen the knowledge of different members of the breast team as well as help ensure the optimal work of the team as a whole.
The conference registration fee structure has been designed specifically to support the participation of breast teams.
The conference will again showcase practice-changing new data and provide delegates with the opportunity to discuss it in sessions with innovative, interactive formats.
EBCC-10 will highlight important regulatory developments in Europe.
A European Parliament resolution has stipulated that by 2016 member states should have enshrined in law that all breast cancer patients are to be treated in a specialised breast centre or unit.
At EBCC-10, we will review the impact this resolution has had so far on the treatment of breast cancer, we will map the status of its implementation and discuss how best to direct our advocacy efforts in 2016 and beyond.
